Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction.
about
Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology.A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members.Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis.Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.PD-1 blockade enhances the antitumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.
P2860
Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Programmed Death Ligand 1 (PD- ...... -mediated apoptosis induction.
@en
type
label
Programmed Death Ligand 1 (PD- ...... -mediated apoptosis induction.
@en
prefLabel
Programmed Death Ligand 1 (PD- ...... -mediated apoptosis induction.
@en
P2093
P2860
P1433
P1476
Programmed Death Ligand 1 (PD- ...... -mediated apoptosis induction.
@en
P2093
Djoke Hendriks
Douwe F Samplonius
Edwin Bremer
Iris Koopmans
Robert J van Ginkel
Valerie R Wiersma
Wijnand Helfrich
P2860
P304
P356
10.1080/2162402X.2016.1202390
P577
2016-07-06T00:00:00Z